Shoji M - Search Results

1

Structure-activity relationships of epolactaene derivatives: structural requirements for inhibition of Hsp60 chaperone activity.

Nagumo Y, Kakeya H, Yamaguchi J, Uno T, Shoji M, Hayashi Y, Osada H. Nagumo Y, et al. Among authors: shoji m. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4425-9. doi: 10.1016/j.bmcl.2004.06.054. Bioorg Med Chem Lett. 2004. PMID: 15357965

2

Triazoyl-phenyl linker system enhancing the aqueous solubility of a molecular probe and its efficiency in affinity labeling of a target protein for jasmonate glucoside.

Tamura S, Inomata S, Ebine M, Genji T, Iwakura I, Mukai M, Shoji M, Sugai T, Ueda M. Tamura S, et al. Among authors: shoji m. Bioorg Med Chem Lett. 2013 Jan 1;23(1):188-93. doi: 10.1016/j.bmcl.2012.10.124. Epub 2012 Nov 6. Bioorg Med Chem Lett. 2013. PMID: 23177786

3

Diastereoselective total synthesis of both enantiomers of epolactaene.

Hayashi Y, Kanayama J, Yamaguchi J, Shoji M. Hayashi Y, et al. Among authors: shoji m. J Org Chem. 2002 Dec 27;67(26):9443-8. doi: 10.1021/jo025641m. J Org Chem. 2002. PMID: 12492351

4

Synthesis and biological comparison of enantiomers of mepenzolate bromide, a muscarinic receptor antagonist with bronchodilatory and anti-inflammatory activities.

Yamashita Y, Tanaka K, Asano T, Yamakawa N, Kobayashi D, Ishihara T, Hanaya K, Shoji M, Sugai T, Wada M, Mashimo T, Fukunishi Y, Mizushima T. Yamashita Y, et al. Among authors: shoji m. Bioorg Med Chem. 2014 Jul 1;22(13):3488-97. doi: 10.1016/j.bmc.2014.04.029. Epub 2014 Apr 30. Bioorg Med Chem. 2014. PMID: 24844758

5

Structure-activity relationship of celecoxib and rofecoxib for the membrane permeabilizing activity.

Yamakawa N, Suzuki K, Yamashita Y, Katsu T, Hanaya K, Shoji M, Sugai T, Mizushima T. Yamakawa N, et al. Among authors: shoji m. Bioorg Med Chem. 2014 Apr 15;22(8):2529-34. doi: 10.1016/j.bmc.2014.02.032. Epub 2014 Mar 12. Bioorg Med Chem. 2014. PMID: 24650702

6

Epoxyquinol B, a naturally occurring pentaketide dimer, inhibits NF-kappaB signaling by crosslinking TAK1.

Kamiyama H, Usui T, Sakurai H, Shoji M, Hayashi Y, Kakeya H, Osada H. Kamiyama H, et al. Among authors: shoji m. Biosci Biotechnol Biochem. 2008 Jul;72(7):1894-900. doi: 10.1271/bbb.80142. Epub 2008 Jul 7. Biosci Biotechnol Biochem. 2008. PMID: 18603781

7

Epoxyquinol B shows antiangiogenic and antitumor effects by inhibiting VEGFR2, EGFR, FGFR, and PDGFR.

Kamiyama H, Kakeya H, Usui T, Nishikawa K, Shoji M, Hayashi Y, Osada H. Kamiyama H, et al. Among authors: shoji m. Oncol Res. 2008;17(1):11-21. doi: 10.3727/096504008784046063. Oncol Res. 2008. PMID: 18488711

8

Fungal metabolite, epoxyquinol B, crosslinks proteins by epoxy-thiol conjugation.

Kamiyama H, Usui T, Uramoto M, Takagi H, Shoji M, Hayashi Y, Kakeya H, Osada H. Kamiyama H, et al. Among authors: shoji m. J Antibiot (Tokyo). 2008 Feb;61(2):94-7. doi: 10.1038/ja.2008.117. J Antibiot (Tokyo). 2008. PMID: 18408330

9

Epolactaene binds human Hsp60 Cys442 resulting in the inhibition of chaperone activity.

Nagumo Y, Kakeya H, Shoji M, Hayashi Y, Dohmae N, Osada H. Nagumo Y, et al. Among authors: shoji m. Biochem J. 2005 May 1;387(Pt 3):835-40. doi: 10.1042/BJ20041355. Biochem J. 2005. PMID: 15603555 Free PMC article.

10

Novel non-peptide inhibitors targeting death receptor-mediated apoptosis.

Kakeya H, Miyake Y, Shoji M, Kishida S, Hayashi Y, Kataoka T, Osada H. Kakeya H, et al. Among authors: shoji m. Bioorg Med Chem Lett. 2003 Nov 3;13(21):3743-6. doi: 10.1016/j.bmcl.2003.08.003. Bioorg Med Chem Lett. 2003. PMID: 14552771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results